, Volume 30, Issue 1, pp 7-9
Date: 08 May 2007

What is the role of CT staging in the management of patients with clinical stage 1 and 2 malignant melanoma?

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

There is a lack of evidence to support CT staging for distant disease in patients with Clinical Stage I and II melanoma. Staging scans, undertaken prior to Sentinel Lymph Node Biopsy (SLNB) in 115 patients with melanoma, between October 2004 and October 2006 were reviewed. CT imaging failed to identify distant site disease in any patient. 67 patients were diagnosed with non-melanoma related abnormalities necessitating further imaging and investigation, ultimately without identifiable benefit in all but one patient. The results of this study further question the need for distant site imaging of melanoma patients prior to SLNB.